Webinar | QED Clinical Development Program Update

ANDO Portugal will be holding a Webinar with QED Therapeutics on 24 September at 6pm (UTC/GMT +1) as part of an innovative series focused on new treatments for skeletal dysplasias.

Details

Innovation & Therapeutics | ANDO Webinar with QED Therapeutics
Title: QED Clinical Development Program Update

Guest: Elena Muslimova MD, PhD and Medical Director for the ACCEL Hypochondroplasia Program.

Organiser: ANDO Portugal
Date: 24 September 2024 - 18:00 (UTC/GMT +1)
Webinar Language: English

Important Topics:
1. Presentation of the clinical programs under study, namely PROPEL (achondroplasia) and ACCEL (hypochondroplasia).
2. Q&A about the studies carried out and the results obtained.
3. The way forward: next steps in the studies.
4. Collaboration: understanding the importance of collaboration between pharmaceutical companies and other stakeholders (patients, families and organisations) in advancing healthcare.

Free Access and Participation:
Participation is open to those interested in skeletal dysplasia care and research. Participate: during the webinar, ask questions in the chat. Missed a webinar? Don't worry, it will be recorded, subtitled and shared on ANDO's website for everyone to access.

How to take part:
Taking part is easy. Simply register for free using the form and you'll receive instructions on how to join the live session. Don't miss this opportunity to keep up with innovation in skeletal dysplasias.